Trials / Completed
CompletedNCT01180868
The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- Jonsson Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the biodistribution of a new agent 1-L-(2 deoxy-2,-18fluoroarabinofuranosyl) cytosine non-invasively in healthy humans and to evaluate whether it can be used to image cancer, autoimmune disease, and inflammation
Conditions
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2011-11-01
- First posted
- 2010-08-12
- Last updated
- 2012-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01180868. Inclusion in this directory is not an endorsement.